BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Drug Abuse Treatment Clinical Trials Network - Northeast Node - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.ctnnortheastnode.org
X-WR-CALDESC:Events for The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230208T120000
DTEND;TZID=America/New_York:20230208T130000
DTSTAMP:20230202T151257Z
CREATED:20230202T151257Z
LAST-MODIFIED:20230202T151257Z
UID:3196-1675857600-1675861200@www.ctnnortheastnode.org
SUMMARY:Comparing Methods of Buprenorphine Treatment Initiation in Patients Using Fentanyl
DESCRIPTION:Presenter: Adam Bisaga\, MD \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nThis talk discusses substance use disorder treatment in a post-COVID world. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nNOTE: To encourage participants to speak freely\, recordings of these roundtables are not available. \nRegister now!
URL:https://www.ctnnortheastnode.org/event/comparing-methods-of-buprenorphine-treatment-initiation-in-patients-using-fentanyl/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230214T120000
DTEND;TZID=America/New_York:20230214T130000
DTSTAMP:20230210T164844Z
CREATED:20230210T164844Z
LAST-MODIFIED:20230210T164844Z
UID:3199-1676376000-1676379600@www.ctnnortheastnode.org
SUMMARY:Screening for Substance Use in Primary Care: Screening Tools and Guidance for Implementation
DESCRIPTION:Presenter: Jennifer McNeely\, MD \nSponsor: American Psychiatric Association (APA) and American Academy of Addiction Psychiatry (AAAP) \nCost: No Fee \nTarget audience: Physicians\, psychologists\, social workers\, physician assistants\, pharmacists\, interprofessional team\, residents/fellows\, medical students\, other mental health clinicians \nCredit Designations Available: AMA PRA Category 1 Credit™\, AAPA Category 1 CME\, Social Work CE Credit\, Nursing Contact Hours\, Pharmacy CE Credit\, Interprofessional Continuing Education (IPCE) Credit \nAbout the webinar: Substance use drives poor health outcomes in the general population. SUD continues to lead to more death and disability than any other preventable condition\, with alcohol being the third leading cause of preventable death in the United States. Drug-related overdoses also continue to climb with > 108\,000 overdose deaths per year as well as the leading all-cause mortality under the age of 50. Primary care is generally not thought of as a place to access mental health care\, but it may be a critical tool in noticing substance use behaviors and proactively loop patients into needed care. This webinar aims to introduce screening tools that can be administered during primary care visits. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nApply the screening guidelines and current state of the evidence to your practice.\nReview and evaluate screening instruments introduced in the webinar.\nConsider screening implementation in general medical settings based on the needs of your current patients.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/screening-for-substance-use-in-primary-care-screening-tools-and-guidance-for-implementation/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230222T120000
DTEND;TZID=America/New_York:20230222T130000
DTSTAMP:20230209T142208Z
CREATED:20230209T142208Z
LAST-MODIFIED:20230209T142208Z
UID:3198-1677067200-1677070800@www.ctnnortheastnode.org
SUMMARY:Illicit Drug Supply: Fentanyl and Xylazine
DESCRIPTION:Presenter: Richard Dawson\, PhD\, Research Professor at the Vermont Center for Behavior and Health at UVM and a Professor Emeritus at the UCLA Department of Psychiatry \nThis presentation will explore current information about fentanyl and xylazine including: drug supply information\, pharmacology\, clinical effects\, medical impacts\, harm reduction and treatment information. Considerations for rural populations will be discussed. \nRegister now! \n 
URL:https://www.ctnnortheastnode.org/event/illicit-drug-supply-fentanyl-and-xylazine/
END:VEVENT
END:VCALENDAR